logo
Coinbase considers applying for federal bank charter

Coinbase considers applying for federal bank charter

Yahoo24-04-2025

This story was originally published on Banking Dive. To receive daily news and insights, subscribe to our free daily Banking Dive newsletter.
Coinbase is considering applying for a federal bank charter, a company spokesperson confirmed, as cryptocurrency firms seek to capitalize on regulatory amiability.
'This is something Coinbase is actively considering but has not made any formal decisions yet,' the spokesperson told Banking Dive, without elaboration.
Coinbase is one of four crypto companies identified by the Wall Street Journal Monday as currently planning to seek a bank charter, alongside crypto custodian BitGo and stablecoin issuers Circle and Paxos.
Spokespeople for Paxos, Circle and BitGo declined to comment.
Just one crypto-native bank has a federal bank charter: Anchorage Digital scored a national trust charter from the Office of the Comptroller of the Currency in 2021. Paxos and a third firm, Protego, received conditional OCC charters that year, too, though the charters expired in 2023 before the firms were able to meet the charters' conditions.
But that's 'highly' likely to change, according to Adam Shapiro, partner and co-founder at financial services advisory and investment firm Klaros Group, 'based on the noises coming out of the OCC, if [crypto companies] submit credible applications.'
The main regulatory shift needed to clear the way for crypto firms to obtain bank charters already happened last month, Shapiro said: The OCC rescinded a Biden-era requirement that banks obtain supervisory non-objection before engaging in crypto-related activities, which was 'obviously a big deterrent to being able to do anything new,' Shapiro said.
One benefit crypto firms would see after obtaining a bank charter, Shapiro said, is direct access to the payments system.
'It puts control of the on and off ramp in the hands of the crypto companies themselves, without having to go through intermediate banks. With some of the challenges with getting banking relationships in this space, you can see why that's attractive, even for firms like Coinbase that have been large and stable enough to maintain a range of banking partners,' Shapiro said.
Also, a federal charter would simplify regulatory compliance for crypto firms that are otherwise state-chartered.
'States have been very welcoming of innovative activity and bringing that within a regulated framework, and at times where the federal pendulum has strongly swung to more regulation and gatekeeping, that's given the crypto industry a way to develop,' Shapiro said.
But there are disadvantages to state regulation, 'not least the need, in many cases, to maintain multiple charters,' Shapiro said. Not all states recognize reciprocity for state trusts, he said, and crypto firms with money transmitter licenses have multiple exams each year covering much of the same ground.
A federal charter would cut down on duplicative requirements.
Current and likely-incoming OCC leadership have long been pro-crypto.
As chairman of the National Credit Union Administration in 2021, current Acting Comptroller Rodney Hood said that the crypto market was 'something vitally important … [to] the overall financial services market,' according to CU Today. And Jonathan Gould, whose confirmation as comptroller awaits a full Senate vote, was the OCC's chief counsel when it granted charters to Anchorage, Paxos and Protego.
Anchorage Digital CEO and co-founder Nathan McCauley told Banking Dive that the firm has 'worked hand-in-hand with the OCC over the last four years to pioneer a path forward for federally regulated crypto banking.'
He called the regulatory clarity that comes with an OCC charter 'second to none.'
'At the end of the day, we think there should be more federally chartered digital asset banks — and we would be proud for others to follow in our footsteps,' McCauley said. 'Institutions, consumers, and the ecosystem as a whole would be better for it.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NYC taxi lender fined $4M over 'fake news' plants
NYC taxi lender fined $4M over 'fake news' plants

New York Post

time42 minutes ago

  • New York Post

NYC taxi lender fined $4M over 'fake news' plants

A New York financier and his publicly traded firm that bankrolled loans to taxi drivers were fined $4 million for planting fake news articles online to boost the company's stock price. Medallion Financial Corp. — which got hit a decade ago as ride-sharing apps like Uber and Lyft began to tank the value of taxi medallions — will have to pay $3 million as part of a settlement after a ruling by Judge Lewis A. Kaplan of the US Southern District of New York. Medallion president Andrew Murstein — who made headlines when he hired Nicki Minaj to perform at his son's bar mitzvah in 2015 — must fork out over $1 million in a ruling on a case brought by the Securities and Exchange Commission, according to a May 29 securities filing. 5 Medallion president Andrew Murstein, seen here at a Yankees game, has been hit with a $1 million fine. Anthony J. Causi The SEC complaint, brought in December 2021 under the agency's President Biden-appointed chair Gary Gensler, contained 'more than sufficient allegations to support the claim that Murstein and Medallion Financial misled investors by withholding information material to Medallion Bank's fair value,' Kaplan wrote in a separate filing. The Post previously reported on Murstein's brazen scheme to secretly pay for 'fake news' stories as the rise of Uber and Lyft caused investors to sour on taxi-related stocks, leaving Medallion's share price floundering. Judge Kaplan ruled that securities laws were broken when the top executive hired media strategists to place at least 50 stories from 2014 to 2017 on sites such as HuffPost and Crain's New York Business. The taxi medallion lender also failed to disclose that the authors of the bogus blogs were being paid, and that many of the stories had been personally tweaked and edited by Murstein. Instead, the posts were written in a way to make it look as if they had been penned by actual investors who were bullish on Medallion stock. 5 Prices for a prized medallion soared to as much as $1 million under Mayor Michael Bloomberg before crashing when ride-sharing apps such as Uber and Lyft cornered the market. NY Post 'Neither Medallion Financial nor Murstein ever disclosed to investors Murstein's conduct in recruiting, paying, and instructing his touters,' Kaplan wrote.. 'Murstein acted knowingly or recklessly in hiring and keeping touters on the Medallion Financial payroll.' The judge found he had gone 'opinion-shopping' when one valuation firm refused to ignore his deteriorating medallion portfolio and accept his inflated view of the company's actual worth of $193 million. It resulted in the value of Medallion's banking unit jumping to $280 million at the end of 2016, from $166 million just two quarters earlier, even as the price of medallions slumped. California PR agent Lawrence Meyers, one of the main communications specialists hired by Murstein, must also pay a $100,000 fine, according to SEC filings. As part of the settlement deal, all defendants neither admit nor deny the allegations, the ruling said. 'Our agreement with the SEC puts this nearly decade-old matter behind us and enables us to apply our full focus to continuing to grow the company,' a Medallion spokesperson told The Post on Wednesday. 'It removes the distraction, cost, and uncertainty of continued litigation and is in the best interest of the Company and our shareholders.' 5 Murstein splashed the cash on getting Nicki Minaj to perform at his son's bar mitzvah in 2015. Evan Agostini/Invision/AP News of the settlement was first reported by American Banker on Tuesday. The brash boss and his father, Leon, raked in more than $42 million from 2002 to 2014, according to the New York Times. Aside from spending lavishly on the 'WAP' singer, Medallion Financial bought up professional lacrosse and NASCAR teams, the paper reported. 'One wonders if the SEC is going easy on them a bit, due to the change in administration or lack of staff,' a source close to the situation told The Post. 'That should give investors pause for thought if boards and executives can get away with such behavior.' President Trump-nominated SEC Chair Paul Atkins replaced Gensler. Rebecca Fike, a partner at Vinson & Elkins and a former SEC enforcement attorney, added that it shows 'a desire to wrap up actions that were initiated under the previous administration.' 'I expect the Atkins SEC to favor quicker resolutions and accept much lower civil penalties, particularly where the staff cannot show a corporate benefit from the fraudulent acts,' she told The Post. 5 Medallion made a mint offering loans to low-income drivers who wanted to get a permit to drive NYC's iconic yellow cabs. Christopher Sadowski The company's stock closed Wednesday at $9.50. By law, there are only 13,587 taxi medallions in New York City, and each yellow cab must have a medallion linked to it. Prices for a prized medallion soared to as much as $1 million under Mayor Michael Bloomberg. But they plunged under tougher competition from the ride-sharing apps, leaving the drivers drowning in debt and piling the pressure on Medallion's profit margins. Medallion went public in 1996. The company had been originally set up by Murstein's taxi-driving father, a Polish immigrant, who started trading some of the cab medallions. 5 The case against Medallion was first brought in December 2021 under Gary Gensler, who was Joe Biden's pick to be chair of the Securities and Exchange Commission. REUTERS A driver would put up roughly a third of the purchase price when buying the permit, with Medallion financing the rest with interest over a fixed period of time. After years of protests from drivers amid the rise of digital rivals, former New York Mayor Bill de Blasio unveiled a deal in November 2021 to cap medallion loans at $170,000 and interest repayments at 5%. Medallion has since tried to shift to more traditional consumer and commercial banking over the past few years.

Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM)
Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM)

Yahoo

time43 minutes ago

  • Yahoo

Analyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM)

Insmed Incorporated (NASDAQ:INSM) is among the 13 Biotech Stocks with Huge Upside Potential. Kelly Shi of Jefferies has given Insmed Incorporated (NASDAQ:INSM) a buy recommendation, stating that she is confident in the TPIP treatment's impending Phase 2 data for pulmonary arterial hypertension. A biopharmaceutical research team taking notes in front of a laboratory's microscope. Shi anticipates a substantial decrease in pulmonary vascular resistance, the main outcome of the trial, of 20%, which is regarded as a definite success. If the results are encouraging, TPIP may replace Tyvaso, the current standard treatment. On June 4, Wells Fargo reaffirmed its Buy recommendation, with a price objective of $107. Shi points out that TPIP's once-daily dosage is a significant benefit over Tyvaso's four-times-daily schedule, which could increase adherence and make it more appealing to patients as well as physicians. The efficacy potential of TPIP is supported by interim study results that show additional advantages in six-minute walk distance (6MWD). Shi expects significant market penetration in light of these considerations, which could lead to an increase in Insmed Incorporated (NASDAQ:INSM)'s valuation. Both analysts highlight that if future trial results live up to predictions, TPIP has the potential to completely change the way that PAHs are treated. Insmed Incorporated (NASDAQ:INSM) is a biopharmaceutical firm that improves the lives of individuals suffering from serious and rare diseases. While we acknowledge the potential of INSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

US Appeals Court Confirms Patent Validity of Acadia's Parkinson's Medication
US Appeals Court Confirms Patent Validity of Acadia's Parkinson's Medication

Yahoo

time43 minutes ago

  • Yahoo

US Appeals Court Confirms Patent Validity of Acadia's Parkinson's Medication

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is among the 13 Biotech Stocks with Huge Upside Potential. It declared that the U.S. Court of Appeals maintained the legality of its composition of matter patent for the medication Nuplazid, which treats psychosis in Parkinson's disease. A research scientist looking through a microscope in a lab, symbolizing the biopharmaceutical company's innovative approach to medical treatments. The verdict supports ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) in its legal struggle with India-based MSN Laboratories and upholds a December 2023 ruling by the U.S. District Court of Delaware. A later patent claim with the same priority date cannot be declared invalid by the court. According to CEO Catherine Owen Adams, Nuplazid's patent protection has been extended to 2030. The 34 mg capsule is also protected by a separate formulation patent that runs through 2038. The U.S. FDA authorized Nuplazid in 2016 to treat delusions and hallucinations linked to psychosis in Parkinson's disease. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)'s legal stance in a different action against Aurobindo Pharma was further strengthened by the latest decision. When taken as a whole, these results solidify the company's portfolio of intellectual property in the face of generic competition, guaranteeing prolonged market exclusivity for its flagship neurological medication. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharmaceutical firm that specializes in the creation and marketing of medications that treat uncommon diseases and disorders of the central nervous system. While we acknowledge the potential of ACAD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store